Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Crohn's disease: we are in it for the long haul. Interview by Paul C Adams.

Literature DB >> 19006852

Crohn's disease: we are in it for the long haul. Interview by Paul C Adams.

Remo Panaccione.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2008 PMID： 19006852 PMCID： PMC2661296 DOI： 10.1155/2008/836576

Source DB: PubMed Journal: Can J Gastroenterol ISSN： 0835-7900 Impact factor: 3.522

Keyword Cloud
References

× No keyword cloud information.

12 in total

1. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study.

Authors: W A Faubion; E V Loftus; W S Harmsen; A R Zinsmeister; W J Sandborn
Journal: Gastroenterology Date: 2001-08 Impact factor: 22.682

2. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.

Authors: B G Feagan; R N Fedorak; E J Irvine; G Wild; L Sutherland; A H Steinhart; G R Greenberg; J Koval; C J Wong; M Hopkins; S B Hanauer; J W McDonald
Journal: N Engl J Med Date: 2000-06-01 Impact factor: 91.245

3. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study).

Authors: Magne Henriksen; Jørgen Jahnsen; Idar Lygren; Jostein Sauar; Øystein Kjellevold; Tom Schulz; Morten H Vatn; Bjørn Moum
Journal: Inflamm Bowel Dis Date: 2006-07 Impact factor: 5.325

4. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.

Authors: Paul Rutgeerts; Robert H Diamond; Mohan Bala; Allan Olson; Gary R Lichtenstein; Weihang Bao; Kamlesh Patel; Douglas C Wolf; Michael Safdi; Jean Frederic Colombel; Bret Lashner; Stephen B Hanauer
Journal: Gastrointest Endosc Date: 2006-03 Impact factor: 9.427

9. Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives.

Authors: R Modigliani; J Y Mary; J F Simon; A Cortot; J C Soule; J P Gendre; E Rene
Journal: Gastroenterology Date: 1990-04 Impact factor: 22.682

10. Long term prognosis in ulcerative colitis--based on results from a regional patient group from the county of Copenhagen.

Authors: C Hendriksen; S Kreiner; V Binder
Journal: Gut Date: 1985-02 Impact factor: 23.059

Crohn's disease: we are in it for the long haul. Interview by Paul C Adams.

1. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study.

2. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.

3. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study).

4. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.

5. Disease activity courses in a regional cohort of Crohn's disease patients.

6. Frequency of glucocorticoid resistance and dependency in Crohn's disease.

7. Course of ulcerative colitis: analysis of changes in disease activity over years.

Review 8. Azathioprine for maintaining remission of Crohn's disease.

9. Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives.

10. Long term prognosis in ulcerative colitis--based on results from a regional patient group from the county of Copenhagen.